A senior scientist at the US CDC has resigned, warning that changes in leadership may weaken the country’s vaccine program.

Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can ...

In advance of this week's CDC vaccine advisory meeting, HHS Secretary Robert F. Kennedy Jr. restacked the committee, claiming ...

T he Centers for Disease Control used to have a vaccine advisory panel made of well-respected experts. This panel, the Advisory Committee for Immunization Practices (or ACIP), wou ...

The FDA has approved clesrovimab, marketed as Enflonsia, for the prevention of RSV lower respiratory tract disease in ...

In the wake of Robert F. Kennedy Jr.’s abrupt revamp of the CDC’s Advisory Committee on Immunization Practices, details from ...

RFK Jr.’s newly appointed CDC vaccine panel will not review HPV or meningitis vaccines but will vote on thimerosal, a ...

Kennedy said that removing all 17 members of the CDC's vaccine advisory panel was "necessary to reestablish public confidence ...

Dr. Fiona Havers, who studied medicine at the University of Washington, says the wholesale dismissal of the CDC's scientific ...

The U.S. Centers for Disease Control and Prevention panel of vaccine experts will vote on shots for respiratory syncytial virus and influenza at a meeting scheduled for June 25 and 26, according to ...